COVID-19, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), has led to unprecedented disruption across all aspects of life, including health, social systems, and the global economy. The pandemic, triggered by this newly discovered, genetically mutated strain of the virus, has resulted in millions of deaths worldwide and is recognized as the deadliest pandemic in modern history. In response, scientists worldwide are working tirelessly to develop the best diagnostic tests, vaccines, and therapeutic regimens to manage and ultimately overcome this crisis.
COVID-19 Signs and Symptoms
The symptoms of COVID-19 vary widely depending on the severity of the infection. Most individuals experience mild to moderate symptoms, which may resemble mild pneumonia and may or may not require hospitalization. However, COVID-19 can also lead to severe, life-threatening conditions, especially in vulnerable populations.
Common symptoms of COVID-19 include fever, dry cough, fatigue, loss of taste or smell, rhinorrhea, sore throat, myalgia, diarrhea, conjunctivitis, skin rashes, and discoloration of fingers or toes. In more severe cases, patients may develop acute respiratory distress, chest pain, or pressure, and even loss of speech or movement, which require immediate medical attention.
Transmission of COVID-19
COVID-19 is a highly contagious respiratory infection. The virus primarily enters the body through the respiratory tract and mucosal surfaces. Transmission occurs mainly through contact with respiratory droplets, which are expelled when an infected person talks, breathes, coughs, or sneezes. The virus can also be transmitted through contact with contaminated surfaces. Older adults and individuals with underlying health conditions, such as cardiovascular disease, diabetes, chronic respiratory disease, and cancer, are particularly at risk for severe illness.
Insight into the COVID-19 Biospecimens for Research
To support the ongoing research into COVID-19, we offer an extensive collection of COVID-19 biospecimens for research purposes. Our inventory includes a wide range of patient samples, such as human serum, plasma, and swab tests (both oropharyngeal and nasopharyngeal), which are tested for SARS-CoV-2-IgG, SARS-CoV-2-IgM, and SARS-CoV-2-RNA.
Types of COVID-19 Biospecimens Available:
-
Clinically Confirmed Patients: These COVID-19 positive samples come with molecular test results confirming the presence of SARS-CoV-2. They include detailed clinical information such as patient demographics, clinical diagnosis, disease onset, clinical presentation, and exposure details. Available in small, medium, and large volumes, these specimens include human plasma, serum, saliva, and nasopharyngeal and oropharyngeal swab tests, making them ideal for COVID-19 research.
-
Symptomatic Patients: These samples are from donors who have tested positive for SARS-CoV-2 and exhibit symptoms of COVID-19. The collection includes human plasma, serum, saliva, and nasopharyngeal and oropharyngeal swab test samples, available in various volumes for research purposes.
-
Vaccinated Donors: We provide human serum and plasma samples collected from individuals who have been vaccinated against COVID-19. These biospecimens, available in various volumes, are sourced from vaccinated individuals across different countries.
-
Screening Population: This category includes biospecimens from both symptomatic and asymptomatic donors, including human serum, plasma, nasopharyngeal, and oropharyngeal swab tests. These samples are valuable for studying populations exposed to COVID-19 risk factors.
-
Healthy Donor Samples: These biospecimens are derived from self-reported healthy, asymptomatic donors who have been tested for COVID-19. They include serum and plasma samples, as well as nasopharyngeal and oropharyngeal swab tests, available in small, medium, and large volumes.
-
COVID-19 Serial Sets: This category includes clinically confirmed positive and negative human serum, plasma, saliva samples, and swab tests. Each set contains 7-8 samples collected from individual patients, making them ideal for longitudinal COVID-19 research.
-
COVID-19 Remnant Swab Test Samples: These samples consist of oropharyngeal and nasopharyngeal remnant swabs accumulated from accredited laboratories. They are available in various matrices such as UTM, VTM, Aptima Swab, E-Swab, Liquid Amies, and Saline.
Additionally, we offer COVID-19 panels that include a predefined set of positive and negative human biospecimens, ideal for assay validation, COVID-19 research, and diagnostic development.
Streamlined COVID-19 Biospecimen Procurement
Central BioHub is committed to facilitating cutting-edge research by providing ethically obtained, meticulously preserved, and precisely handled COVID-19 biospecimens. Our experts assist you at every step of the biospecimen procurement process, ensuring that your research needs are met with the highest quality samples.
With Central BioHub, you can accelerate your COVID-19 research by ordering SARS-CoV-2 samples online. Our platform ensures secure and hassle-free procurement of COVID-19 biomarker samples, with reliable delivery to support your mission to advance scientific breakthroughs.
Explore advanced search options to procure covid 19 biospecimens for research by using Clinical Diagnosis, ICD-10-CM codes, Matrix, and Laboratory Parameters.